Zdolność patentowa wynalazków biotechnologicznych a godność ludzka w regulacji Wspólnoty Europejskiej

• Autorzy: Agata Skorek

Warianty tytułu

Patentability of biotechnological inventions and human dignity in provisions of the European Community

• Języki publikacji: PL

Abstrakty

Przybliżono kontrowersje etyczne dotyczące zdolności patentowej wynalazków biotechnologicznych. Przedstawiono zdolność patentową wynalazków biotechnologicznych pochodzenia ludzkiego w prawie wspólnotowym w kontekście ludzkiej godności.

EN

The question of patentability of biotechnological inventions is considered from many points of view, because of special value and particular features distinguishing this kind of inventions from others. In the area of biotechnology the question of granting exclusive rights on the use of inventions (or, in some cases, discoveries) to individuals and of letting them dictate prices gives rise to serious doubts of both legal and ethical nature. The article covers this matter from perspective of human dignity, which implies limitation of its scope to biotechnological inventions of human origin. The task of standardization of provisions relating legal aspects of biotechnology - among others to biotechnological inventions, has been undertaken by the European Community. Patent protection in the EC legal system takes place on two levels: the system of European patents and systems of national patents. At present the basic act of the European Union in this field is the Directive 98/44/EC of 6 July 1998 concerning legal protection of biotechnological inventions. It specifies legal limitations of admissibility of patenting biotechnological inventions and serves as the basis for the European Patents Office for granting patents in the area of biotechnology. The article focuses upon Articles 5 and 6 of the Directive, which regard patenting of materials of human origin (genes). Reference is made not only to the content of the Act, but also to its interpretations, opinions and comments from by various institutions (e.g. the International Court of Justice). (original abstract)

Słowa kluczowe

PL

Patenty; Prawo patentowe; Biotechnologia

EN

Patent; Patent law; Biotechnology

• Czasopismo: Studia Europejskie / Centrum Europejskie Uniwersytetu Warszawskiego
• Rocznik: 2008
• Numer: nr 4
• Strony: 101--118

Twórcy

autor

Agata Skorek

Bibliografia

• An initial proposal for a directive, COM (88) 496 final/SYN 159 of 21.10.1988, O.J., C from 10 to 13.01.1989.
• B.A.Brody, Intellectual Property and Biotechnology: The European Debate, "Kennedy Institute of Ethics Journal", nr 2(17)72007, s.69-110.
• COM (95) 661 final, 95/0350 (COD), no. 53, s. 14.
• Commission White Paper for the European Council in Milan (28-29.06.1985), The completion of the internal market, COM (85) 310 final, 14.06.1985, 6 145.
• Decyzja Rady z 25.10.1993 r. dotycząca zawarcia Konwencji o Różnorodności Biologicznej, O.J., L 309, 13.12.1993, s.1-2.
• EGE, Opinion on ethical aspects of human stem cell research and use, Opinion, No. 15, 14,11.2000 r., s.15, pkt 2.6.
• European Parliament resolution on patents for biotechnological inventions, 26.10.2005 r., ust. 4, 5, 13, 14.
• European Group on Ethics in Sciences and New Technologies to the European Commission, Opinion on ethical aspects of patenting inventions involving human stem cells, Opinion no. 16, 7.05.2002 r., Luxembourg 2002, s.6-7.
• European Parliament resolution on patents for biotechnological inventions, 26.10.2005 r., P6_TA(2005)0407, pkt J, K, http://www.europarl.europa.eu/sides/getDoc.do?type=TA&language=EN&reference =P6-TA-2005-0407
• The explanatory memorandum to the Proposal for a European Parliament and Council Directive on the legal protection of biotechnological inventions from 25.01.1996 (96/C 296/03)
• GAEIB, Opinion on the ethical aspects of patenting inventions involving elements of human origin, Opinion no. 8, 25.09.1996 r., s.11, http://europa.eu.intycomm/european_group_ethics/gaeib/en/biotecll.htnVopinion8.pdf
• J.L.Gal, Community Law in relation to processes for the cloning and patentability of inventions relating to the genome and certain humain. cells, "Revue du Droit de l'Union Europeenne" no. 4/2000, s.835-853 w: EGE, Opinion on ethical aspects of patenting..., 7.05.2002 r., Luxembourg 2002, s.26.
• K.Gibiński, Stanowisko Prezydium Polskiej Akademii Nauk w sprawie form transgenicznych oraz klonowania i badań nad klonowaniem organizmów z 7 kwietnia 1997 r., "Nauka" nr 3/1997, s.232.
• M.A.Heller, R.S.Eisenberg, Can Patents Deter Innovation? The Anticommons in Biomedical Research, , "Science" no. 5364/1998, vol. 280, s.698-701.
• http://www.iprcommission.org
• http://www.wto.org/english/docs__e/legal_e/legal_e.htm